Immune Checkpoint Inhibitors in Ovarian Cancer: Can We Bridge the Gap Between IMagynation and Reality?

被引：18
|
作者：
Konstantinopoulos, Panagiotis A. [1 ]
Cannistra, Stephen A. [2 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 17期
关键词：
NEOADJUVANT CHEMOTHERAPY; T-CELLS; PEMBROLIZUMAB;
D O I：
10.1200/JCO.21.00571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：1833 / +
页数：7
相关论文
共 50 条
  • [1] Purchasing: Can we bridge the gap between strategy and daily reality?
    Knoppen, Desiree
    Saenz, Maria J.
    [J]. BUSINESS HORIZONS, 2015, 58 (01) : 123 - 133
  • [2] Immune checkpoint inhibitors in ovarian cancer: where do we stand?
    Leary, Alexandra
    Tan, David
    Ledermann, Jonathan
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2021, 13
  • [3] Immune checkpoint inhibitors in ovarian cancer: where do we go from here?
    Yoon, Won-Hee
    DeFazio, Anna
    Kasherman, Lawrence
    [J]. CANCER DRUG RESISTANCE, 2023, 6 (02) : 358 - 377
  • [4] Application of PARP inhibitors combined with immune checkpoint inhibitors in ovarian cancer
    Xiao, Fen
    Wang, Zhibin
    Qiao, Liu
    Zhang, Xiu
    Wu, Nayiyuan
    Wang, Jing
    Yu, Xing
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [5] Immune checkpoint inhibitors in colorectal cancer: dream and reality comment
    Andre, Thierry
    Cohen, Romain
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2022, 7 (01): : 4 - 6
  • [6] Immune Checkpoint Inhibitors in Cancer Therapy-How Can We Improve Clinical Benefits?
    Baxevanis, Constantin N. N.
    [J]. CANCERS, 2023, 15 (03)
  • [7] Emerging role of immune checkpoint inhibitors in the treatment of ovarian cancer
    Lorusso, Domenica
    Ceni, Valentina
    Muratore, Margherita
    Salutari, Vanda
    Nero, Camilla
    Pietragalla, Antonella
    Ciccarone, Francesca
    Carbone, Vittoria
    Daniele, Gennaro
    Scambia, Giovanni
    [J]. EXPERT OPINION ON EMERGING DRUGS, 2020, 25 (04) : 445 - 453
  • [8] Bibliometric and visual analysis of immune checkpoint inhibitors for ovarian cancer
    Meng, Shunyao
    Song, Shiyi
    Yin, Rutie
    [J]. ASIAN JOURNAL OF SURGERY, 2024, 47 (07) : 3205 - 3206
  • [9] Immune Checkpoint Inhibitors: A New Opportunity in the Treatment of Ovarian Cancer?
    Mittica, Gloria
    Genta, Sofia
    Aglietta, Massimo
    Valabrega, Giorgio
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (07)
  • [10] How can we manage the cardiac toxicity of immune checkpoint inhibitors?
    Poto, Remo
    Marone, Giancarlo
    Pirozzi, Flora
    Galdiero, Maria Rosaria
    Cuomo, Alessandra
    Formisano, Luigi
    Bianco, Roberto
    Della Corte, Carminia Maria
    Morgillo, Floriana
    Napolitano, Stefania
    Troiani, Teresa
    Tocchetti, Carlo G.
    Mercurio, Valentina
    Varricchi, Gilda
    [J]. EXPERT OPINION ON DRUG SAFETY, 2021, 20 (06) : 685 - 694
12345